If you are wondering whether Pfizer is genuinely good value or just looks cheap on the surface, this article walks through what the current numbers are really saying about the stock.
Pfizer shares last closed at US$27.22, with returns of 3.0% over 7 days, 7.7% over 30 days, 8.1% year to date, 13.4% over 1 year, a 25.7% decline over 3 years and 0.6% over 5 years. Together, these figures give you a mixed picture of recent performance and shifting risk sentiment.
Recent headlines around Pfizer have focused on how the business looks beyond its pandemic era profile and on how the market is assessing its long term product pipeline and capital allocation decisions. These themes sit in the background as investors weigh up whether the recent…
